Heptobarbital
Heptobarbital is a barbiturate derivative developed in the 1950s. It has sedative, anxiolytic, and hypnotic properties. Heptobarbital was formerly used in a similar manner to other sedative-hypnotic drugs as a preanesthetic medication and treatment for insomnia, but is not commonly used today.
Pharmacology[edit | edit source]
Heptobarbital, like other barbiturates, is believed to act as a positive allosteric modulator of the GABA_A receptor in the brain. This action enhances the effect of the neurotransmitter GABA on the receptor, leading to increased inhibitory effects on the central nervous system.
Side Effects[edit | edit source]
Common side effects of Heptobarbital include drowsiness, dizziness, nausea, and vomiting. More serious side effects can include respiratory depression, dependence, and withdrawal symptoms upon discontinuation.
History[edit | edit source]
Heptobarbital was first synthesized in the 1950s as part of a wave of new barbiturate drugs. It was used for several decades as a treatment for insomnia and as a preanesthetic, but has largely been replaced by newer drugs with fewer side effects and lower risk of dependence.
See Also[edit | edit source]
References[edit | edit source]
Heptobarbital Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD